Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells

被引:37
作者
Tanaka, Norina [1 ]
Wang, Yan-Hua [1 ]
Shiseki, Masayuki [1 ]
Takanashi, Minoko [2 ]
Motoji, Toshiko [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan
[2] Japanese Red Cross Tokyo Metropolitan Blood Ctr, Blood Preparat Dept, Tokyo, Japan
关键词
PRAME; siRNA; Acute leukemia; Cell cycle; Apoptosis; Differentiation; CHRONIC MYELOID-LEUKEMIA; BREAST-CANCER; ANTIGEN; MELANOMA; GENE; IDENTIFICATION; RECEPTOR;
D O I
10.1016/j.leukres.2011.04.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The preferentially expressed antigen of melanoma (PRAME) is known as a tumor-associated antigen, but its function in leukemia remains unclear. We investigated the function with small interfering RNA (siRNA)-induced knockdown of PRAME in a K562 cell line. After PRAME siRNA transfection, proliferation was suppressed and cell cycle analysis showed G(0)/G(1) arrest, followed by apoptosis. PRAME siRNA-treated cells also showed changes in the genes affecting erythroid differentiation. We examined the PRAME expression levels and the S phase population of 32 acute leukemia patients at the time of diagnosis and relapse. An increase of the S phase population was accompanied by an increase of PRAME expression at relapse. Our results suggest that PRAME plays an important role in disease progression in acute leukemia. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1219 / 1225
页数:7
相关论文
共 24 条
[1]   PRAME expression and clinical outcome of breast cancer [J].
Epping, M. T. ;
Hart, A. A. M. ;
Glas, A. M. ;
Krijgsman, O. ;
Bernards, R. .
BRITISH JOURNAL OF CANCER, 2008, 99 (03) :398-403
[2]   The human tumor antigen repressor of retinoic acid PRAME is a dominant receptor signaling [J].
Epping, MT ;
Wang, LM ;
Edel, MJ ;
Carlée, L ;
Hernandez, M ;
Bernards, R .
CELL, 2005, 122 (06) :835-847
[3]   Transcriptional control of granulocyte and monocyte development [J].
Friedman, A. D. .
ONCOGENE, 2007, 26 (47) :6816-6828
[4]   mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies [J].
Greiner, J ;
Ringhoffer, M ;
Taniguchi, M ;
Li, LI ;
Schmitt, A ;
Shiku, H ;
Döhner, H ;
Schmitt, M .
INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (05) :704-711
[5]   Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches [J].
Greiner, Jochen ;
Schmitt, Michael ;
Li, Li ;
Giannopoulos, Krzysztof ;
Bosch, Katrin ;
Schmitt, Anita ;
Dohner, Konstanze ;
Schlenk, Richard F. ;
Pollack, Jonathan R. ;
Dohner, Hartmut ;
Bullinger, Lars .
BLOOD, 2006, 108 (13) :4109-4117
[6]   Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor [J].
Ikeda, H ;
Lethe, B ;
Lehmann, F ;
VanBaren, N ;
Baurain, JF ;
DeSmet, C ;
Chambost, H ;
Vitale, M ;
Moretta, A ;
Boon, T ;
Coulie, PG .
IMMUNITY, 1997, 6 (02) :199-208
[7]   Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2 [J].
Kitajima, K ;
Tanaka, M ;
Zheng, J ;
Yen, H ;
Sato, A ;
Sugiyama, D ;
Umehara, H ;
Sakai, E ;
Nakano, T .
BLOOD, 2006, 107 (05) :1857-1863
[8]   Anti-proliferative effect of the abl tyrosine kinase inhibitor STI571 on the P-glycoprotein positive K562/ADM cell line [J].
Kotaki, M ;
Motoji, T ;
Takanashi, M ;
Wang, YH ;
Mizoguchi, H .
CANCER LETTERS, 2003, 199 (01) :61-68
[9]   Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia [J].
Luetkens, Tim ;
Schafhausen, Phillipe ;
Uhlich, Frederike ;
Stasche, Tim ;
Akbulak, Ruken ;
Bartels, Britta M. ;
Hildebrandt, York ;
Gontarewicz, Arthur ;
Kobold, Sebastian ;
Meyer, Sabrina ;
Gordic, Maja ;
Bartels, Katrin ;
Lajmi, Nesrine ;
Cao, Yanran ;
Kroeger, Nicolaus ;
Bokemeyer, Carsten ;
Bruemmendorf, Tim H. ;
Atanackovic, Djordje .
LEUKEMIA RESEARCH, 2010, 34 (12) :1647-1655
[10]   Growth stimulatory effect of thrombopoietin on the blast cells of acute myelogenous leukaemia [J].
Motoji, T ;
Takanashi, M ;
Motomura, S ;
Wang, YH ;
Shiozaki, H ;
Aoyama, M ;
Mizoguchi, H .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (03) :513-516